LOCOREGIONAL RECURRENCE
Clinical trials for LOCOREGIONAL RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONAL RECURRENCE trials appear
Sign up with your email to follow new studies for LOCOREGIONAL RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop breast Cancer's comeback
Disease control Recruiting nowThis study is testing whether adding the drug ribociclib to standard hormone therapy can better prevent breast cancer from returning in patients who have already had a local recurrence surgically removed. The trial will enroll 200 adults with hormone-sensitive, HER2-negative brea…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims to stop breast Cancer's second strike
Disease control Recruiting nowThis study is for people whose hormone-positive, HER2-negative breast cancer has returned in the breast or nearby lymph nodes after initial treatment. It tests if adding a drug called abemaciclib to standard hormone therapy is better at preventing the cancer from coming back or s…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Heating up the fight: can adding heat to radiation better control returning breast cancer?
Disease control Recruiting nowThis study aims to find the best way to treat breast cancer that has returned in the breast or nearby lymph nodes after initial treatment. It will follow 500 patients who receive standard repeat radiation, with or without added heat therapy (hyperthermia), to see which approach b…
Matched conditions: LOCOREGIONAL RECURRENCE
Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC